rss
Br J Ophthalmol 1999;83:588-594 doi:10.1136/bjo.83.5.588
  • Original Article
    • Clinical science

Modelling uveal melanoma

  1. Alexander J E Fossa,
  2. Ian A Creeb,
  3. Paul J Dolinc,
  4. John L Hungerfordd
  1. aDirectorate of Ophthalmology, University Hospital, Queen’s Medical Centre, Nottingham NG7 2UH, bDepartment of Pathology, Institute of Ophthalmology, Bath Street, London EC1V 9EL, cTuberculosis Program, World Health Organisation, Geneva, Switzerland, dOncology Clinic, Moorfields Eye Hospital, City Road, London EC1V 2PD
  1. Alexander Foss, Directorate of Ophthalmology, University Hospital, Queen’s Medical Centre, Nottingham NG7 2UH.
  • Accepted 25 November 1998

Abstract

BACKGROUND/AIM There has been no consistent pattern reported on how mortality for uveal melanoma varies with age. This information can be useful to model the complexity of the disease. The authors have examined ocular cancer trends, as an indirect measure for uveal melanoma mortality, to see how rates vary with age and to compare the results with their other studies on predicting metastatic disease.

METHODS Age specific mortality was examined for England and Wales, the USA, and Canada. A log-log model was fitted to the data. The slopes of the log-log plots were used as measure of disease complexity and compared with the results of previous work on predicting metastatic disease.

RESULTS The log-log model provided a good fit for the US and Canadian data, but the observed rates deviated for England and Wales among people over the age of 65 years. The log-log model for mortality data suggests that the underlying process depends upon four rate limiting steps, while a similar model for the incidence data suggests between three and four rate limiting steps. Further analysis of previous data on predicting metastatic disease on the basis of tumour size and blood vessel density would indicate a single rate limiting step between developing the primary tumour and developing metastatic disease.

CONCLUSIONS There is significant underreporting or underdiagnosis of ocular melanoma for England and Wales in those over the age of 65 years. In those under the age of 65, a model is presented for ocular melanoma oncogenesis requiring three rate limiting steps to develop the primary tumour and a fourth rate limiting step to develop metastatic disease. The three steps in the generation of the primary tumour involve two key processes—namely, growth and angiogenesis within the primary tumour. The step from development of the primary to development of metastatic disease is likely to involve a single rate limiting process.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.